Edit Module

Patentability Of Frontline Plus Formulation Claims Confirmed



Published:

Merial announced today the United States Patent and Trademark Office reconfirmed the patentability of formulation claims covering Merial’s Frontline Plus, a flea and tick control product.

“The ultimate result is that we expect some of the products infringing the formulation claims to be removed from the market.” says Judy Jarecki-Black, PhD, Esq., head of intellectual property with Merial, an animal health pharmaceutical company.

Additional information regarding companies involved with potential formulation infringement and actionable steps was expected to be released later this week, according to earlier information from a public relations representative. The release of the additional information is now expeted in coming weeks, according to Merial.

“We are pleased that the patent office confirmed the patentability of Merial’s inventions directed at fipronil and (S)-methoprene containing spot-on compositions,” Dr. Jarecki-Black says. “Merial is also pursuing litigation against other manufacturers in cases where it believes its patents have been violated. We plan to continue to vigorously defend our patent rights and continue our strong support of the veterinary profession.”

<Home>

Edit Module
Edit ModuleShow Tags

Archive »Read More

FDA Warns Veterinary Community of Accidental Overdose in Dogs From Sileo

It remains undetermined whether improper use of Zoetis' noise-aversion treatment's ring-stop mechanism is to blame.

NAVTA Pursues Registered Veterinary Nurse Credential

The National Association of Veterinary Technicians in America seeks to unite the profession under a single title.

Maine’s New Opioid Rules Confusing to Veterinarians

The rules, veterinarians say range from being unethical to not applicable to them.

Add your comment:
Edit Module
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module